Eun Jung Jang

Eun Jung Jang

Auto-generated profile, based on publicly available information

Eun Jung Jang

Korea Disease Control and Prevention Agency, Cheongju, Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJi Joo Lee
Ji Joo Lee
YCYoung June Choe
Young June Choe
HJHyeongseop Jeong
Hyeongseop Jeong
MKMoonsu Kim
Moonsu Kim
SKSeonggon Kim
Seonggon Kim
YPYoung-Joon Park
Young-Joon Park
Lee JJ, et al. J Korean Med Sci. 2021 Dec;36(50):e346. https://doi.org/10.3346/jkms.2021.36.e346

1 January 2008 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
TOTae Young Oh
Tae Young Oh
BAByung Ok Ahn
Byung Ok Ahn
EJEun Jung Jang
Eun Jung Jang
JPJoo Sang Park
Joo Sang Park
SPSang Jong Park
Sang Jong Park
KHKi-Baik Hahm
Ki-Baik Hahm
Quality of ulcer healing (QOUH) is defined as ideal ulcer healing featuring with the fine granular ulcer scar, high functional restoration and the resistance to recurrence. This study was designed to compare the rates of QOUH achievement in rat gastric ulcer model between acid suppressant treated group and gastroprotectant treated group accompanied with elucidations of molecular mechanisms. Serosal injection of acetic acids for generating gastric ulcer and intraperitoneal (ip) injection of recombinant interleukin 1-beta (IL-1beta) for recurring healed ulcer was done in SD rats. The 72 rats were divided into three groups according to treatment as follows; Group I, no further treatment, Group II, 8 weeks treatment of omeprazole, and Group III, 8 weeks of gastroprotectant treatment. IL-1beta was administered for ulcer recurrence after 28 weeks of acetic acid injection. At four weeks after gastric ulcerogenesis, 58.3% (7/12) of active gastric ulcer were converted to healing stage in Group III, but 16.7% (2/12) in Group II and none in Group I, for which significant levels of epidermal growth factor, mucin, and pS2/trefoil peptide1 were contributive to these accelerated healings of Group III. ip injections of rIL-1beta (200 microg/kg) at 28 weeks after acetic acid injection led to 100% of ulcer recurrence in Group I and 75.0% in Group II, but only 16.7% of Group III rats showed ulcer recurrence. Significantly attenuated levels of inflammatory cytokines including IL-2, transforming growth factor-alpha (TNF-alpha), cyclooxygenase-2 (COX-2), nitrotyrosine were responsible for the resistance to ulcer recurrence in Group III. Conclusively, gastroprotectant might be prerequisite in order to achieve ideal QOUH through significant inductions of remodeling.

2 August 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
EJEun Jung Jang
Eun Jung Jang
YCYoung June Choe
Young June Choe
GYGo‐Woon Yun
Go‐Woon Yun
SWSEONG JIN WANG
SEONG JIN WANG
UCU Jin Cho
U Jin Cho
YPYoung-Joon Park
Young-Joon Park
To better understand the epidemiology of SARS‐CoV‐2 reinfections, we analyzed national data from South Korean who were followed longitudinally from January 2020 to April 2022. We conducted a nationwide retrospective cohort study to estimate possible SARS‐CoV‐2 reinfection rates in all residents in South Korea, with at least two episodes of laboratory‐confirmed SARS‐CoV‐2 infection by reverse‐transcriptase polymerase chain reaction or rapid antigen test (RAT) performed at least 45 or more days between both episodes, between January 2020 and April 2022. There were 16 130 855 laboratory‐confirmed SARS‐CoV‐2 cases in South Korea, with 55 841 (346.2 per 100 000; or 0.3% of all infections) cases of possible reinfections. The reinfection rate has increased from 6.0 cases per 100 000 during Pre‐Delta period to 128.0 cases per 100 000 and 355.1 cases per 100 000 during Delta and Omicron periods, respectively. Persons with one dose of vaccination had the highest reinfection rate of 642.2 per 100 000, followed by unvaccinated persons (536.2/100 000) and two‐dose vaccinated persons (406.3/100 000). Our finding suggests that the majority of possible reinfections occurred following the emergence of new variants.

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JLJu Hee Lee
Ju Hee Lee
JHJi Hae Hwang
Ji Hae Hwang
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
KLKil Hun Lee
Kil Hun Lee
YPYoung-Joon Park
Young-Joon Park
Lee JH, et al. J Korean Med Sci. 2023 Aug;38(34):e269. https://doi.org/10.3346/jkms.2023.38.e269

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YKYoo-Yeon Kim
Yoo-Yeon Kim
YCYoung June Choe
Young June Choe
JKJia Kim
Jia Kim
RKRyu Kyung Kim
Ryu Kyung Kim
EJEun Jung Jang
Eun Jung Jang
YPYoung-Joon Park
Young-Joon Park
Kim YY, et al. J Korean Med Sci. 2023 Mar;38(11):e87. https://doi.org/10.3346/jkms.2023.38.e87

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
RKRyu Kyung Kim
Ryu Kyung Kim
YCYoung June Choe
Young June Choe
EJEun Jung Jang
Eun Jung Jang
CCChungman Chae
Chungman Chae
JHJi Hae Hwang
Ji Hae Hwang
DKDonghyok Kwon
Donghyok Kwon
Kim RK, et al. J Korean Med Sci. 2023 Nov;38:e396. https://doi.org/10.3346/jkms.2023.38.e396